课题基金 / 基金详情

Novel Early Detection Strategy for Liver Cancer using Hepatitis B Splice Variants to Expediate Diagnosis and Improve Treatment Outcome

Novel Early Detection Strategy for Liver Cancer using Hepatitis B Splice Variants to Expediate Diagnosis and Improve Treatment Outcome
使用乙型肝炎剪接变体的肝癌早期检测新策略以促进诊断并改善治疗结果
批准号:
nhmrc : GNT1145977
负责人:
A/Pr Peter Revill
金额:
$94.36万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

A/Pr Peter Revill的其他基金

相似基金

相关文献

中文摘要
翻译
乙肝病毒(乙肝病毒)导致肝癌,这是仅有的几种发病率上升的癌症之一。我们已经证明,被称为剪接变体的较小版本的乙肝病毒与肝癌的相关性甚至更强-剪接变体水平较高的人患肝癌的可能性是后者的3倍以上。我们将通过深入研究剪接变体如何改变病毒和宿主细胞来促进肝癌,从而找出原因。
英文摘要
Hepatitis B virus (HBV) causes liver cancer, which is one of the only cancers that is increasing in prevalence. We have shown that smaller versions of HBV, termed splice variants, are even more strongly associated with liver cancer- people with higher levels of the splice variants were over 3 times more likely to have liver cancer. We will find out why, by thoroughly studying how the splice variants alter the virus and the host cell to promote liver cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Early Detection Strategy for Liver Cancer using Hepatitis B Splice Variants to Expediate Diagnosis and Improve Treatment Outcome
  • 批准号:
    nhmrc : 1145977
  • 项目类别:
    Project Grants
  • 资助金额:
    $63.8万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Peter Revill
  • 依托单位:
Investigating the host determinants of viral clearance versus collateral pathology in chronic infection
RNA-mediated control of HIV gene expression
  • 批准号:
    nhmrc : 1011043
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $39.37万
  • 财政年份:
    2011
  • 负责人:
    A/Pr Peter Revill
  • 依托单位:
国内基金
海外基金
玉米Edk1(Early delayed kernel 1)基因的克隆及其在胚乳早期发育中的功能研究